Other HDAC6 inhibitors recently developed, such as ACY-1215, WT161, and MPT0G413 confirmed enhanced MM cytotoxicity in combination with PIs [119,121,211,212]. This evidence concerns the gene HDAC6 and Miyoshi myopathy.